Masimo Corporation (MASI) recently announced positive results form its 21-month clinical study on the impact of the Masimo Patient SafetyNet remote monitoring and clinician notification system. Results indicated that continuous pulse oximetry monitoring and clinician notification in post-surgical patients on the general floor leads to a significant drop in key clinical outcome measures, such as 65% fewer rescue events, 48% fewer ICU transfers and reduced annualized ICU time by 135 days.

Masimo Patient SafetyNet combines the performance of Masimo SET pulse oximetry at the point of care with remote monitoring and wireless clinician notification via pager. This is the first study on adults using Masimo SET pulse oximetry technology that demonstrated improved patient safety while reducing the cost.

Masimo SET pulse oximetry enables clinicians to continuously and non-invasively measure multiple blood constituents that previously required invasive procedures. The multiple blood constituents measured are total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), etc. Masimo SET pulse oximetry eliminates the need to draw blood and wait for results. This helps physicians to immediately detect and treat potentially fatal conditions.

Masimo develops, manufactures and markets a family of non-invasive blood monitoring systems that consist of a monitor, circuit board and sensors. The systems are primarily used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. Hypoxemia, low blood-oxygen levels, can cause brain damage and death. Hyperoxemia, high-blood oxygen levels, can permanently damage eyes and cause blindness. Masimo is a leader in the pulse oximetry monitoring equipment market. The company’s closest competitors are Haemonetics Corp. (HAE) and Becton, Dickinson and Co. (BDX).

Zacks Investment Research

1. (MASI) Masimo Corporation Can Now Earn While Patients Test Device EffectivenessMasimo Corporation (MASI) has recently received a new Current Procedural Terminology (CPT) code from the...
2. (MASI) Masimo Corporation in Expansion ModeMasimo Corp. (MASI) recently announced the expansion of its corporate campus in Irvine, California with the...
3. (MASI) Masimo Completes Conversion of New CustomerMasimo Corp. (MASI) reported that its new customer, Brookdale University Hospital and Medical Center in...
4. (MASI) Masimo Corporation Earns FDA New Product ApprovalMasimo Corporation (MASI) recently received the U.S. Food and Drug Administration (FDA) approval for its...
5. (MASI) Masimo Corporation Renews Deal with Advocate Health CareMasimo Corporation (MASI) announced that one of its prominent customers, Advocate Health Care, has recently...
6. (CFN) CareFusion Corporation Enters Agreement with MasimoCareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding...

Search Posts by Tag: BDX | Becton Dickinson Company | HAE | Haemonetics Corporation | MASI | Masimo Corporation | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: BDX | Becton Dickinson Company | HAE | Haemonetics Corporation | MASI | Masimo Corporation | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author